Dan has more than 20 years of experience representing clients across the health care and life sciences sectors, including in the digital health industry, providing strategic counseling and leading civil fraud and abuse investigations.

Dan represents a diverse set of clients, such as hospitals, health systems, physicians, post-acute care entities, digital health and medical technology companies, life sciences organizations, and investors on a broad range of complex regulatory, compliance, privacy, and transactional matters. Dan assists clients in navigating evolving federal and state laws and regulations regarding pricing and reimbursement, licensing and accreditation, state corporate practice of medicine, privacy and consent, federal and state anti-kickback statutes, and federal and state self-referral provisions. He additionally oversees regulatory due diligence in mergers, acquisitions, and other transactional matters.

Drawing upon knowledge gained from representing a wide range of health industry sector clients and leveraging his extensive regulatory and compliance background, Dan represents clients in fraud and abuse matters in federal and state courts around the country, with an emphasis on matters involving the civil False Claims Act and similar state laws. Dan also conducts internal investigations and leads mediations and settlement negotiations.

Through the course of his practice, Dan regularly interacts with federal and state entities such as the Department of Justice, the Department of Health and Human Services, and state administrative and enforcement agencies.

In law school, Dan was a staff member of the William & Mary Law Review and an articles editor for the William & Mary Environmental Law and Policy Review.